| Ident. | Authors (with country if any) | Title |
|---|
| 000177 (2012) |
A. Marquet [Suisse] ; K. Kupas [Allemagne] ; A. Johne [Allemagne] ; B. Astruc [France] ; A. Patat [France] ; S. Krösser [Allemagne] ; A. Kovar [Allemagne] | The Effect of Safinamide, a Novel Drug for Parkinson's Disease, on Pressor Response to Oral Tyramine: A Randomized, Double-Blind, Clinical Trial |
| 000368 (2011) |
Santiago Perezlloret [Argentine, France] ; Gabriela Nano [Argentine] ; Andrea Carrosell [Argentine] ; Elkan Gamzu [États-Unis] ; Marcelo Merello [Argentine] | A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients |
| 000440 (2010) |
Fanny Schmiijt [France] ; Gael Le Douaron [France] ; Pierre Champy [France] ; Majid Amar [France] ; Blandine Seon-Meniel [France] ; Rita Raisman-Vozari [France] ; Bruno Figadere [France] | Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons |
| 000564 (2009) |
M. M. Sarr [Sénégal, France] ; S. Pinto [France] ; L. Jankowski [France] ; B. Teston [France] ; A. Purson [France] ; A. Ghio [France] ; J. Regis [France] ; J.-C. Peragut [France] ; F. Viallet [France] | Contribution de la mesure de la pression intra-orale pour la compréhension des troubles de la coordination pneumophonique dans la dysarthrie parkinsonienne |
| 000756 (2008) |
Maria Skaalum Petersen [Danemark] ; Jonrit Halling [Danemark] ; Sara Bech ; Lene Wermuth [Danemark] ; Pal Weihe [Danemark] ; Flemming Nielsen [Danemark] ; Poul J. J Rgensen [Danemark] ; Esben Budtz-J Rgensen [Danemark] ; Philippe Grandjean [Danemark, États-Unis] | Impact of dietary exposure to food contaminants on the risk of Parkinson's disease |
| 000868 (2007) |
Caroline Moreau [France] ; Canan Ozsancak [France] ; Jean-Louis Blatt [France] ; Philippe Derambure [France] ; Alain Destée [France] ; Luc Defebvre [France] | Oral festination in Parkinson's disease : Biomechanical analysis and correlation with festination and freezing of gait |
| 000959 (2006) |
Thomas Dufour [France] ; Jean-Louis Coeuriot [France] ; Benoit Lefevre [France] ; Damien Jolly [France] | Candidoses buccales : facteurs de risque chez la personne âgée dépendante en institution |
| 000D84 (2003) |
Charles Crevoisier [Suisse] ; Patricia Zerr [France] ; Francoise Calvi-Gries [France] ; Turid Nilsen [Norvège] | Effects of food on the pharmacokinetics of levodopa in a dual-release formulation |
| 000F42 (2002) |
J. S. Schneider [États-Unis] ; M. Giardiniere [États-Unis] ; P. Morain [France] | Effects of the prolyl endopeptidase inhibitor S17092 on cognitive deficits in chronic low dose MPTP-treated monkeys |
| 001175 (2000) |
A. Boireau [France] ; P. Dubedat [France] ; F. Bordier [France] ; A. Imperato [France] ; S. Moussaoui [France] | The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP+ accumulation |
| 001329 (1999) |
C. Thalamas [France] ; A. Taylor [Royaume-Uni] ; C. Brefel-Courbon [France] ; S. Eagle [Royaume-Uni] ; K. Fitzpatrick [Royaume-Uni] ; O. Rascol [France] | Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease |
| 001423 (1998) |
E. Bezard [France] ; J.-M. Stutzmann [France] ; C. Imbert [France] ; T. Boraud [France] ; A. Boireau [France] ; C. E. Gross [France] | Riluzole delayed appearance of parkinsonian motor abnormalities in a chronic MPTP monkey model |
| 001454 (1998) |
C. Brefel [France] ; C. Thalamas [France] ; S. Rayet [France] ; A. Lopez-Gil [Royaume-Uni] ; K. Fitzpatrick [Royaume-Uni] ; S. Bullman [Royaume-Uni] ; D. R. Citerone [Royaume-Uni] ; A. C. Taylor [Royaume-Uni] ; J. L. Montastruc [France] ; O. Rascol [France] | Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients |
| 001455 (1998) |
L. Fauchier [France] ; D. Babuty [France] ; M. L. Autret [France] ; P. Poret [France] ; P. Cosnay [France] ; J. P. Fauchier [France] | Effect of flecainide on heart rate variability in subjects without coronary artery disease or congestive heart failure |
| 001463 (1998) |
M. G. Murer [France] ; G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. C. Garcia [Argentine] ; Yves Agid [France] ; O. Gershanik [Argentine] ; R. Raisman-Vozari [France] | Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions |
| 001636 (1996) |
O. Rascol [France] ; A. J. Lees ; J. M. Senard [France] ; Z. Pirtosek ; J. L. Montastruc [France] ; D. Fuell | Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease |
| 001705 (1995) |
L. Lebreton [France] ; O. Curet [France] ; S. Gueddari [France] ; FATHI MAZOUZ [France] ; S. Bernard [France] ; C. Burstein [France] ; R. Milcent [France] | Selective and potent monoamine oxidase type B inhibitors : 2-substituted 5-aryltetrazole derivatives |
| 001741 (1995) |
P. Limousin [France] ; P. Pollak [France] ; J. P. Pfeffen ; C. L. Tournier-Gervason [France] ; R. Dubuis ; J. E. Perret [France] | Acute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, in Parkinson's disease |
| 001790 (1994) |
J. Dow [France] ; F. Piriou ; E. Wolf [France] ; B. D. Dulery [France] ; K. D. Haegele | Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans |
| 001842 (1993) |
F. Goulley [France] ; Y. Wolmark [France] ; I. Bourdeix [France] ; P. D. Chaumet-Riffaud [France] | Introduction du Parlodel® en association précoce à la lévodopa dans le traitement de la maladie de Parkinson : comparaison de deux progressions posologiques |
| 001885 (1993) |
J. M. Senard [France] ; O. Rascol [France] ; G. Durrieu [France] ; M. A. Tran [France] ; M. Berlan [France] ; A. Rascol ; J. L. Montastruc | Effects of Yohimbine on plasma catecholamine levels in orthostatic hypotension related to Pakinson disease or multiple system atrophy |
